Cargando…

Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry

Background: Validated biomarkers are needed to identify patients at increased risk of immune-related adverse events (irAEs) to immune checkpoint blockade (ICB). Antibodies directed against endogenous antigens can change after exposure to ICB. Methods: Patients with different solid tumors stratified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Music, Milena, Iafolla, Marco, Soosaipillai, Antoninus, Batruch, Ihor, Prassas, Ioannis, Pintilie, Melania, Hansen, Aaron R., Bedard, Philippe L., Lheureux, Stephanie, Spreafico, Anna, Razak, Albiruni Abdul, Siu, Lillian L., Diamandis, Eleftherios P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707117/ https://www.ncbi.nlm.nih.gov/pubmed/33299547 http://dx.doi.org/10.12688/f1000research.22715.1

Ejemplares similares

A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lim, Bryant, et al.
Publicado: (2019)

Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry
por: Cretu, Daniela, et al.
Publicado: (2014)

Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis
por: Iafolla, Marco A J, et al.
Publicado: (2020)

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line
por: Vasiliou, Stella K., et al.
Publicado: (2022)

Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
por: Ren, Annie, et al.
Publicado: (2021)

Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden
por: Ren, Annie He, et al.
Publicado: (2020)

Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers
por: Cretu, Daniela, et al.
Publicado: (2015)

Discovery of novel plasma biomarker ratios to discriminate traumatic brain injury
por: Chen, Michelle, et al.
Publicado: (2019)

Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index
por: Day, Daphne, et al.
Publicado: (2019)

Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry
por: Kagedan, Daniel, et al.
Publicado: (2012)

A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9
por: Filippou, Panagiota, et al.
Publicado: (2017)

Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
por: Begcevic, Ilijana, et al.
Publicado: (2016)

Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis
por: Sohaei, Dorsa, et al.
Publicado: (2023)

Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics
por: Leung, Felix, et al.
Publicado: (2018)

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
por: Makawita, Shalini, et al.
Publicado: (2013)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

Towards personalized tumor markers
por: Kulasingam, Vathany, et al.
Publicado: (2017)

OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery
por: DORN, JULIA, et al.
Publicado: (2015)

Discovery of novel glioma serum biomarkers by proximity extension assay
por: Ghorbani, Atefeh, et al.
Publicado: (2023)

Aberrant expression of kallikrein‐related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion
por: Delaunay, Tiphaine, et al.
Publicado: (2017)

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy
por: Cunningham, Morven, et al.
Publicado: (2021)

Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
por: Korbakis, Dimitrios, et al.
Publicado: (2017)

A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events
por: Janse van Rensburg, Helena J., et al.
Publicado: (2023)

Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment
por: Aghel, Nazanin, et al.
Publicado: (2021)

Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery
por: Prassas, Ioannis, et al.
Publicado: (2012)

Deciphering the peptidome of urine from ovarian cancer patients and healthy controls
por: Smith, Christopher R, et al.
Publicado: (2014)

Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring
por: Konvalinka, Ana, et al.
Publicado: (2016)

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy
por: Spiliopoulou, Pavlina, et al.
Publicado: (2023)

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
por: Cindy Yang, S. Y., et al.
Publicado: (2021)

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab
por: Watson, Geoffrey Alan, et al.
Publicado: (2022)

Cancer patients’ experiences with immune checkpoint modulators: A qualitative study
por: Ala‐Leppilampi, Kari, et al.
Publicado: (2020)

Proteomic Signatures of the Desmoplastic Invasion Front Reveal Collagen Type XII as a Marker of Myofibroblastic Differentiation During Colorectal Cancer Metastasis
por: Karagiannis, George S., et al.
Publicado: (2012)

An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
por: Taylor, Kirsty, et al.
Publicado: (2020)

Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetes
por: Van, Julie A. D., et al.
Publicado: (2020)

Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy
por: Araujo, Daniel V, et al.
Publicado: (2021)

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease
por: Patra, Kalicharan, et al.
Publicado: (2018)

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression
por: Begcevic, Ilijana, et al.
Publicado: (2018)

Electronic field effect detection of SARS-CoV-2 N-protein before the onset of symptoms
por: Novodchuk, I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ijdosfmolma3h6kd0mivonafd1